FDA Approves Mounjaro to Reduce Heart Attack and Stroke Risk in Type 2 Diabetes
The U.S. Food and Drug Administration has authorized Eli Lilly’s injectable diabetes drug Mounjaro (tirzepatide) to reduce the risk of heart attack, stroke, and cardiovascular death in high-risk adults with ... Read More